Drugs / ALK-depot SQ mites
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00310492 Comparator | Apr 2006 → May 2009 | atopic eczema | ALK-Abelló A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALK-depot SQ mites | “This trial is performed to assess the efficacy and safety of ALK-depot SQ mites for treatment of atopic dermatitis” NCT00310492 ↗ |
| Route | Subcutaneous | “Subcutaneous injections with ALK-depot SQ mites to 100,000 SQ-U” NCT00310492 ↗ |